Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Biden Admin: We’re ‘Flagging Problematic Posts’ For Social Media Platforms, Tracking Vaccine ‘Misinformation’

White House Press Secretary Jen Psaki admitted on Thursday…
Read more

Notre Dame Students, Faculty, Alumni Complain About Plans To Put Chick-Fil-A On Campus

Notre Dame Students, Faculty, Alumni have made complaints…
Read more

Capitol Police To Use Same Surveillance Equipment Troops Used Against Terrorists In Iraq, Afghanistan

The United States Capitol Police (USCP) is poised to begin…
Read more